SRB RADIOPHARMA HOLDING AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO: AT
Anders Tuv1978
Chairman of the board: AT
Anders Tuv1978
Years since formation: 6 years; since Jan 29, 2019
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 300,000; 1 share class
Total number of shareholders: 3; companies
Belongs to group of

Financials

Annual total result 2023: 57,600,228; NOK
Total equity 2023: 14,955,724; NOK

Last update: Sep 11, 2024

Management

Management / administration

Name	Role	Shares
AT Anders Tuv 1978	Managing Director/CEO	-

Board

Name	Role	Shares
AT Anders Tuv 1978	Chairman	-
ØS Øyvind Sverre Bruland 1952	Board Member	5.62 % indirectly
RH Roy Hartvig Larsen 1962	Board Member	59.09 % indirectly

Others

Name	Role	Shares
K KPMG AS	Auditor	-

Top 10 individual shareholders

Name	Role	Shares
RH Roy Hartvig Larsen 1962	Board Member	59.09 % indirectly
ØS Øyvind Sverre Bruland 1952	Board Member	5.62 % indirectly

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Number of shares	Share
S SCIENCONS AS	Ordinary shares	177,280	59.09 %
R RADFORSK INVESTERINGSSTIFTELSE	Ordinary shares	105,864	35.29 %
B BLAAHAUGEN AS	Ordinary shares	16,856	5.62 %

Last update: May 24, 2024

Group structure

SCIENCONS AS
Total operating income 2023: NOK 6,667
Operating profit 2023: NOK -510,432
Employees: 0

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	0	0	0
Annual Total Result	57,600,228	0	0
Total assets	21,699,266	9,381,204	28,883
Total liabilities	6,743,542	0	0
Total equity	14,955,724	9,381,204	28,883

P&L

Year	2023	2022	2021
Total operating income	0	0	0
Total operating costs	0	0	0
Operating result	0	0	0
Financial income/costs	64,343,770	0	0
Profit before tax	64,343,770	0	0
Total tax & extraordinary income/cost	6,743,542	0	0
Annual Total Result	57,600,228	0	0

Balance overview

Year	2023	2022	2021
Total fixed assets	7,513,605	9,351,200	0
Total current assets	14,185,661	30,004	28,883
Total assets	21,699,266	9,381,204	28,883
Short term debt	6,743,542	0	0
Long term debt	0	0	0
Total liabilities	6,743,542	0	0
Contributed capital	300,000	9,381,200	30,000
Retained earnings	14,655,724	4	-1,117
Total equity	14,955,724	9,381,204	28,883
Total equity and liabilities	21,699,266	9,381,204	28,883

SRB RADIOPHARMA HOLDING AS922 128 766